Singh et al analyzed 5 randomized trials comparing tiotropium mist to placebo, and found a 46% relative increased risk of all-cause mortality among the treated arms.
Tiotropium mist (Respimat) increases mortality risk, authors say
Tiotropium mist (Respimat) increases…
Tiotropium mist (Respimat) increases mortality risk, authors say
Singh et al analyzed 5 randomized trials comparing tiotropium mist to placebo, and found a 46% relative increased risk of all-cause mortality among the treated arms.